Funding Opportunities for Researchers

In keeping with the LCRF mission, our grant program provides funding for research into the prevention, diagnosis, treatment and cure of lung cancer. It is designed to fund innovative projects across a variety of diverse topics and along the full spectrum of basic, translational, and clinical research. To learn more about research projects that have been previously funded by LCRF, please visit our Previously Funded Research page. Information for investigators seeking funding (including any current requests for proposals) can be found below.

The 2019 application cycle for all LCRF funding opportunities is now closed. Once additional information becomes available, details will be posted on this website and announced via our mailing list.

About Our Grants

LCRF Pilot Grant Program

The LCRF Pilot Grant Program supports high-risk, high-reward research projects investigating a wide variety of topics related to lung cancer. Eligible areas of research include but are not limited to:

  • Improving our understanding of lung cancer biology
  • Prevention and screening for early detection
  • Identification of new biomarkers and the development of targeted therapies
  • Development of more effective and safer therapies
  • Psychosocial research including supportive measures for people with lung cancer and their families
  • Quality of care and outcomes research for the improvement of healthcare standards and overall patient outcomes

LCRF Pilot Grants provide a maximum of $150,000 in funding over a period of two years to early- and mid-career investigators (within ten years of faculty appointment). For full details, please refer to the request for proposals on the LCRF Pilot Grant Program award page.

LCRF Research Grant on Disparities in Lung Cancer

With support from the Stavros S. Niarchos Foundation for Charity in memory of Kathryn Louloudis, LCRF will fund two research projects in 2019 with a focus on overcoming disparities in lung cancer. These grants will provide $150,000 over a period of two years to investigators of any career level. For complete details, please refer to the request for proposals and full details on the award page.

Pfizer-LCRF Competitive Research Grant

The Lung Cancer Research Foundation and Pfizer Global Medical Grants are collaborating to support several research projects focused on understanding ways to improve clinical practices for side effect management for non-small cell lung cancer (NSCLC) patients receiving targeted therapies. This collaborative funding mechanism was designed to support innovative health services research proposals that leverage multidisciplinary approaches to improve the management of targeted therapy toxicities. While the application deadline for this program has passed, additional updates and the list of grantees will be published once they are announced this fall.

Mailing List

To receive announcements and other updates related to LCRF funding opportunities, you may subscribe to our mailing list using the form below. You may opt out of these communications at any time.

   Please leave this field empty


Additional Questions

Any other questions about the LCRF scientific grant program may be addressed to or via phone at 212.588.1902.